Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706
What this trial is testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+2 more
Aclaris Therapeutics, Inc. 110
Early research (Phase 1)Study completedNCT03802162
What this trial is testing

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Who this might be right for
Alzheimer's Disease (AD)
Chong Kun Dang Pharmaceutical 60
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Large-scale testing (Phase 3)Ended earlyNCT04339413
What this trial is testing

Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 116
Early research (Phase 1)Looking for participantsNCT07218081
What this trial is testing

A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.

Who this might be right for
Alzheimer Dementia (AD)
Augusta University 12
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Not applicableLooking for participantsNCT07341009
What this trial is testing

Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Time Perception
University Hospital, Caen 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Early research (Phase 1)Study completedNCT02026271
What this trial is testing

Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic Oligoastrocytoma
Alaunos Therapeutics 40
Not applicableStudy completedNCT03761199
What this trial is testing

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators

Who this might be right for
Quality of LifeAtopic Dermatitis
University School of Physical Education, Krakow, Poland 24
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Large-scale testing (Phase 3)Study completedNCT00337571
What this trial is testing

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Who this might be right for
Behavioral SymptomsAutistic Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 218
Early research (Phase 1)Study completedNCT05827653
What this trial is testing

MAD Study of NX210c

Who this might be right for
Healthy Elderly
Axoltis Pharma 29
Testing effectiveness (Phase 2)Study completedNCT01998841
What this trial is testing

Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 252
Not applicableNot Yet RecruitingNCT07105956
What this trial is testing

Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease (AD)
Nanjing First Hospital, Nanjing Medical University 8
Large-scale testing (Phase 3)Study completedNCT00056524
What this trial is testing

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Who this might be right for
Alzheimer's DiseaseStrokeParkinson's Disease+1 more
Avanir Pharmaceuticals 600
Testing effectiveness (Phase 2)Study completedNCT03417986
What this trial is testing

Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers

Who this might be right for
Alzheimer Disease
Immungenetics AG 20
Testing effectiveness (Phase 2)Study completedNCT04555941
What this trial is testing

The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer DiseaseCognitive Decline
Taipei Medical University Shuang Ho Hospital 54
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Study completedNCT00939822
What this trial is testing

Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
University of Wisconsin, Madison 88
Next Page